RePORT International Resources

The global burden of tuberculosis infection and the need to prevent progression to active disease highlight the importance of generating robust and policy-relevant evidence for tuberculosis preventive treatment (TPT). This guidance presents a structured framework to support the generation of high-quality evidence on new TPT regimens, addressing persistent limitations in available data, including low certainty of evidence, incomplete reporting and insufficient consideration of key decision-making criteria.

Developed by WHO “The purpose of the manual is to provide guidelines and supporting material for sites embarking on STEPS chronic disease risk factor surveillance.” While focus is non-communicable diseases useful information for communicable disease e.g., STEPS instrument.

The TB digital platform offers dashboards displaying global TB data—from overall trends to specific sources like prevalence surveys. It brings together data from all countries and makes it easier to access and understand through clear, user-friendly visuals.

The database provides the most up-to-date information on clinical trials, operational research, and other studies related to TB and MDR-TB.

The 25th meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was held in Geneva, Switzerland, from 5 to 9 May 2025. The Committee considered a total of 59 applications, including 31 proposals for the addition of new medicines or medicine classes, 10 proposals for new indications for currently listed medicines, three proposals for the addition of new formulations of currently listed medicines, one proposal for the removal of a currently listed medicine, and 14 other applications relevant to the Model Lists and the WHO AWaRe classification of antibiotics. This report summarizes the evidence considered and the recommendations made by the Expert Committee in updating the WHO Model Lists of Essential Medicines.

The WHO Global Tuberculosis Programme's newsletter for World TB Day 2025, which highlights the theme "Yes! We Can End TB: Commit. Invest. Deliver." The newsletter calls for urgent action to turn global commitments into results, increase funding, and scale up interventions that are proven to be effective, especially for drug-resistant TB. It includes key messages from various global leaders, such as the WHO Director-General, Dr. Tedros, and author John Green, highlighting the need for solidarity and sustained momentum to end TB

This webinar, commemorating World TB Day 2026, covered global TB data, new guidelines, and calls to action.